During the past decade, CHU Saint-Etienne Hôpital Nord - Service de dermatologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Saint-Etienne Hôpital Nord - Service de dermatologie" are "Basal Cell Carcinoma" (2 trials), "Infantile Hemangioma" (1 trials), "Psoriasis Vulgaris" (1 trials), "Psoriasis of Scalp" (1 trials) and "Scalp Psoriasis" (1 trials). Many other conditions were trialed in "CHU Saint-Etienne Hôpital Nord - Service de dermatologie" in a lesser frequency.

Most popular intervention types in "CHU Saint-Etienne Hôpital Nord - Service de dermatologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Calcipotriol plus betamethasone dipropionate gel (LEO 80185)" (1 trials), "Calcipotriol, (calcipotriol + betamethasone)" (1 trials), "LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)" (1 trials) and "Vismodegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Saint-Etienne Hôpital Nord - Service de dermatologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CHU Saint-Etienne Hôpital Nord - Service de dermatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CHU Saint-Etienne Hôpital Nord - Service de dermatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Saint-Etienne Hôpital Nord - Service de dermatologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".